QEQ-278

N/A

Report date: 2026/02/18 20:02:09

Base Information

Drug NameQEQ-278
Drug Alias NameQEQ-278
ClassificationBiologics
Mechanisms of ActionNKG2-D type II integral membrane protein modulators
TargetsNKG2-D type II integral membrane protein
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of Head and NeckEsophageal Squamous Cell Carcinoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesSingapore +[9] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of Head and NeckEsophageal Squamous Cell Carcinoma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A